Sphera Funds Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-250,000
| Closed | -$24.8M | – | 106 |
|
|
2019
Q3 | $24.8M | Hold |
250,000
| – | – | 3.84% | 6 |
|
|
2019
Q2 | $23.1M | Hold |
250,000
| – | – | 3.16% | 8 |
|
|
2019
Q1 | $23.6M | Sell |
250,000
-215,000
| -46% | -$18.8M | 2.15% | 11 |
|
|
2018
Q4 | $29.8M | Buy |
+465,000
| New | +$34.3M | 3.36% | 5 |
|
|
2018
Q2 | – | Sell |
-319,000
| Closed | -$28.5M | – | 144 |
|
|
2018
Q1 | $28.5M | Buy |
319,000
+10,000
| +3% | +$960K | 4.32% | 4 |
|
|
2017
Q4 | $32.2M | Buy |
309,000
+34,000
| +12% | +$3.84M | 3.78% | 3 |
|
|
2017
Q3 | $40.1M | Buy |
275,000
+25,000
| +10% | +$3.41M | 5.72% | 2 |
|
|
2017
Q2 | $32.5M | Hold |
250,000
| – | – | 5.52% | 2 |
|
|
2017
Q1 | $31.1M | Buy |
250,000
+70,000
| +39% | +$8.38M | 6.08% | 2 |
|
|
2016
Q4 | $20.8M | Buy |
180,000
+70,000
| +64% | +$7.8M | 5.27% | 3 |
|
|
2016
Q3 | $11.5M | Sell |
110,000
-45,000
| -29% | -$4.87M | 1.87% | 12 |
|
|
2016
Q2 | $15.3M | Buy |
155,000
+55,000
| +55% | +$5.69M | 3.97% | 6 |
|
|
2016
Q1 | $10M | Sell |
100,000
-47,200
| -32% | -$4.86M | 2.17% | 11 |
|
|
2015
Q4 | $17.6M | Buy |
147,200
+27,200
| +23% | +$3.15M | 2.58% | 9 |
|
|
2015
Q3 | $13M | Sell |
120,000
-40,000
| -25% | -$4.96M | 1.66% | 14 |
|
|
2015
Q2 | $18.5M | Buy |
160,000
+90,000
| +129% | +$10.3M | 1.81% | 11 |
|
|
2015
Q1 | $8.07M | Buy |
+70,000
| New | +$8.36M | 0.84% | 23 |
|
Other funds holding CELG
Sphera Funds Management's CELG Position: Q4 2019 in Review
Sphera Funds Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 250,000 shares — an estimated $24.8M sold.
Sphera Funds Management first reported a position in CELG in Q1 2015 and held it in 17 quarters. The position peaked at $40.1M in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Sphera Funds Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Sphera Funds Management sold 250,000 Celgene Corp shares in Q4 2019, an estimated $24.8M.
- Sphera Funds Management first reported a position in Celgene Corp in Q1 2015 and held it in 17 quarters.
- Sphera Funds Management's Celgene Corp position peaked at $40.1M in Q3 2017.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Sphera Funds Management's 13F filing for Q4 2019, filed 13 Feb 2020.